Predictmedix (QAI) AI Stock Analysis

8 Followers

Predictmedix

(CNQX:QAI)

Select Model

Rating:42Neutral

Price Target:CAD 0.05▲(112.00% Upside)

Action:reiterated

Date:02/28/26

The score is driven primarily by very weak financial performance (minimal revenue, ongoing losses, negative free cash flow, and negative equity). Technical indicators are mixed but generally soft (negative MACD and price below key moving averages), and valuation is constrained by ongoing losses and no dividend support.

Positive Factors

Low reported debtNear-zero reported debt provides structural financial flexibility relative to highly leveraged peers. Over the next 2–6 months this reduces insolvency risk, eases interest burdens, and increases optionality to raise capital or invest in product development without heavy fixed financing costs.

Negative Factors

Negative shareholders' equityDeeply negative equity reflects cumulative losses and materially weakens the balance sheet. Over months this limits financial flexibility, can impair counterparty confidence, restricts access to traditional financing, and raises the likelihood of dilutive recapitalizations if revenues don't stabilize.

Predictmedix (QAI) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 4.23M
Dividend Yield: ―
Average Volume (3M): 80.15K
Price to Earnings (P/E): -9.1
Beta (1Y): 0.88
Revenue Growth: ―
EPS Growth: 23.08%
Country: Canada
Employees: 0
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Predictmedix Business Overview & Revenue Model

Company Description

Predictmedix Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. The company operates in two segments, Workplace Health and Safety, and Healthcare. It offe...

How the Company Makes Money

null

Predictmedix Financial Statement Overview

Summary

Financials are very weak: minimal and inconsistent revenue, persistent large net losses, consistently negative operating/free cash flow, and a balance sheet with negative equity since 2023. Low reported debt and reduced cash burn in 2025 are positives, but the company still lacks durable revenue traction and remains dependent on financing.

Income Statement

8Very Negative

Balance Sheet

12Very Negative

Cash Flow

10Very Negative

Financial statement breakdown
Breakdown	TTM	Apr 2025	Jan 2024	Apr 2023	Apr 2022	Apr 2021
Income Statement
Total Revenue	0	0	0	35.02K	134.82K	0
Gross Profit	-53.55K	-155.31K	-167.63K	26.62K	84.82K	-3,509
EBITDA	-849.06K	-788.14K	-1.82M	-1.91M	-1.80M	-1.93M
Net Income	-1.18M	-1.18M	-1.99M	-2.07M	-1.88M	-1.93M
Balance Sheet
Total Assets	485.90K	131.95K	481.33K	717.74K	1.24M	1.00M
Cash, Cash Equivalents and Short-Term Investments	313.74K	0	36.87K	79.25K	211.30K	480.05K
Total Debt	0	0	0	37.87K	0	15.19K
Total Liabilities	1.29M	1.45M	625.14K	871.12K	349.67K	135.35K
Stockholders Equity	-799.49K	-1.32M	-143.82K	-153.39K	886.99K	868.29K
Cash Flow
Free Cash Flow	-761.17K	-36.87K	-1.64M	-678.85K	-1.95M	-1.27M
Operating Cash Flow	-761.17K	-36.87K	-1.64M	-534.17K	-1.53M	-1.08M
Investing Cash Flow	0	0	0	-144.68K	-418.12K	-195.01K
Financing Cash Flow	1.07M	0	1.60M	546.80K	1.68M	261.12K

Predictmedix Technical Analysis

Technical Analysis SentimentNegative

Last Price0.03

Price Trends

50DMA0.03Negative

100DMA0.03Negative

200DMA0.04Negative

Market Momentum

MACD-0.00Positive

RSI47.00Neutral

STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:QAI, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 47.00 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:QAI.

Predictmedix Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:QAI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:BLO	45Neutral	CAD 46.81M	-12.59	-232.36%	―	―	-84.43%
TSE:PINK	44Neutral	CAD 22.25M	-1.15	-303.05%	―	35.27%	58.34%
TSE:QAI	42Neutral	CAD 5.75M	-9.06	123.63%	―	―	23.08%
TSE:VPT	37Underperform	CAD 14.47M	-5.36	56.40%	―	89.06%	37.62%

* Healthcare Sector Average

Performance Comparison

TSE:QAI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:QAI	Predictmedix, Inc.	0.03	-0.01	-28.57%
TSE:PINK	Perimeter Medical Imaging Ai Inc	0.15	-0.04	-21.05%
TSE:VPT	VentriPoint Diagnostics	0.07	-0.03	-30.00%
TSE:BLO	Cannabix	0.38	-0.18	-32.14%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Feb 28, 2026

Predictmedix AI Stock Analysis